Arginase biology has been studied in multiple contexts, resulting in the identification of ARG1 and ARG2 as therapeutic targets in cancer [18,44,45,46], as well as potential biomarkers for cancer progression [47,48,49,50]. This evidence concerns the gene ARG1 and cancer.